Skip to Main Content

WASHINGTON — A key Senate Republican renewed his commitment to ramping up oversight of a controversial drug discount program in a hearing Tuesday.

Sen. Lamar Alexander of Tennessee, who chairs the Senate health committee, called for stricter reporting requirements and a closer examination of participants in the so-called 340B program, under which drug makers must give eligible hospitals discounts on their medicines. The hearing was his panel’s third examination of the program.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED